Summary
The plasma disappearance curve following a single intravenous injection of Indocyanine Green (ICG) was analyzed by an established technique and ICG kinetics evaluated for 12 normal control subjects and 57 patients with various hepatic disorders. The two-compartment model was used in this analysis. Three fractional transport rates were determined for the two-pool system: (1) fractional hepatic removal rate; (2) fractional hepatic plasma reflux rate; (3) fractional biliary secretory rate. The mean values and their standard deviation for the three respective rate in normal subjects are: (1) 0.2168 ±0.0199 min-1; (2) 0.0136 ±0.0089 min-1; (3) 0.0642 ±0.0327 min-1. The respective mean rates for 25 patients with biopsy proved hepatic cirrhosis are: (1) 0.0777 ±0.0388 min-1; (2) 0.0127 ±0.0081 min-1; (3) 0.0434 ±0.0188 min-1. The respective means for 7 patients in the acute phase of acute viral hepatitis are: (1) 0.1066 ±0.0498 min-1; (2) 0.0078 ±0.0046 min-1; (3) 0.0218 ±0.0141 min-1. The respective means for 6 patient with almost complete biliary obstruction are: (1) 0.0503 ±0.0211min-1; (2) 0.0717 ±0.0103 min-1; (3) 0.0422 ±0.0190 min-1. Changes in these parameters were dtermined in acute phase and convalescent phase of acute viral hepatitis. This kinetic approach was compared with previous evaluation of sulfobromophthalein (BSP) transport in man and similar results were obtained for the two dyes in normal subjects and in cirrhotic patients.
Similar content being viewed by others
References
Richards TG, Tindal VR, Young A: A modification of the Bromsulphthalein liver function test to predict the dye content, of the liver and bile. Clin Sci 18:499–511 1959.
Barber-Riley G, Goetzee AE, Richards TG, et al: The transfer of Bromsulphthalein from the plasma to the bile in man. Cli Sci 20:149–159, 1961.
Quarfordt SH, Hilderman HL, Valle D, et al: Compartmental analysis of sulfobromophthalein transport in normal patients and patients with hepatic dysfunction. Gastroenterloogy 60:246–255, 1971.
Winkler K: Urinary elimination of Bromsulfalein in man. Scand j Clin Lab Invest 13:44–49, 1961.
Wheeler HO, Cranston WI, Meltzer JI: Hepatic uptake and bliiary excretion of Indocyanine Green in the dog. Proc Soc Exp Biol Med 99:11–14, 1958.
Cherrick GR, Stein SW, Leevy CM. et al: Indocyanine Green: Observations on its physical properties, plasma decay, and hepatic excretion. J Clin Invest 39:592–600, 1960.
Hunton DB, Bollman JL, Hoffman HN: Studies of hepatic function with Indocyanine Green. Gastroenterology 39:713–724, 1960.
Vogin EE, Scott W, Boyd J et al: Effect of probenecid on Indocyanine Green clearance. J Pharm Exp Ther 152:509–515, 1966.
Mikulecky M, Ehrke D, Seifrt A. Indocyanine Green plasma learance in normal human subjects: Rev. Czechoslovak Med. 18:40–44, 1972.
Caesar J, Shaldon S, Chianduss L, et al: The use of Indocyanine Green in the measurement of hepatic blood flow and a test of hepatic function. Clin Sci 21: 43–75, 1961.
Berk PD, Howe RB, Bloomer JR, et al: Studies of bilirubin kinetics in normal adults. J Clin Invest 48:2176–2190, 1969.
Nambu M: Hepatic clearance of Indocyanine Green in liver diseases. Jap J Gastroenterology 63:777–794, 1966.
Schoenfield LJ, McGill DB, Hunton WT, et al.: Studies of chronic idiopathic jaundice (Dubin-Johnson syndrome). 1. Demonstration of hepatic excretory defect. Gastorenterology 44 101–111, 1963.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Namihisa, T., Nambu, M., Kanai, T. et al. Compartmenal analysis of indocyanine green transport in normal subjects and patients with hepatic dysfunction. Gastroenterol Jpn 9, 287–292 (1974). https://doi.org/10.1007/BF02774795
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774795